Edgewise, EWTX

Why Is Andreas Halvorsen Bullish On Edgewise Therapeutics, Inc. (EWTX) Now?
We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against Andreas Halvorsen’s other long-term stock picks.
Stifel Initiates Coverage of Edgewise Therapeutics (EWTX) with Hold Recommendation
Fintel reports that on January 22, 2025, Stifel initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Hold recommendation. Analyst Price Forecast Suggests 84.07% Upside As of December 23,
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Up 8.9% in December
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 6,
Cautious Hold Rating for Edgewise Therapeutics Amid Uncertain Differentiation and Efficacy
Paul Matteis, an analyst from Stifel Nicolaus, has initiated a new Hold rating on Edgewise Therapeutics (EWTX).Invest with Confidence: Follow
Stifel initiates Edgewise Therapeutics stock with Hold rating, $30 target
Stifel analysts began coverage of Edgewise Therapeutics (NASDAQ:EWTX), currently valued at $2.6 billion, with a Hold rating and set a price target of $30.00. According to InvestingPro data, the stock trades at $27.
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
Edgewise Therapeutics promotes Behrad Derakhshan to COO
Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the ...
news.stocktradersdaily9d
How to Take Advantage of moves in (EWTX)
Check the time stamp on this data. Updated AI-Generated Signals for Edgewise Therapeutics Inc. (EWTX) available here: EWTX.
Yahoo Finance2mon
Edgewise Therapeutics, Inc. (EWTX)
BOULDER, Colo., January 13, 2025--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...
Seeking Alpha23d
Edgewise: Remains A Buy After Latest Becker Muscular Dystrophy Data
Edgewise Therapeutics (NASDAQ:EWTX) is building itself up as a good long-term biotech to hang onto. Especially, when you consider that it was able to report positive results from its phase 2 ...
Benzinga.com4mon
Edgewise Therapeutics (NASDAQ:EWTX) Stock Quotes, Forecast and News Summary
Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease Edgewise Therapeutics reports promising Phase 2 results for sevasemten ...
Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans
So notwithstanding the buoyant share price, we think it's well worth asking whether Edgewise Therapeutics' cash burn is too risky. In this report, we will consider the company's annual negative free ...